Ariad Pharmaceuticals Inc., reeling from a series of setbacks that last week forced the Cambridge company to temporarily stop marketing its leukemia drug, said Thursday it is eliminating 160 jobs.
Business - Boston.com, Boston Globe: Business
Thu, 11/07/2013 - 4:08pm
Ariad Pharmaceuticals Inc., reeling from a series of setbacks that last week forced the Cambridge company to temporarily stop marketing its leukemia drug, said Thursday it is eliminating 160 jobs.